Volpara Health Technologies Financing
Volpara Health Technologies Ltd, Corporation just had published form D for $1.50 million equity financing. The date of first sale was . Volpara Health Technologies Ltd is expected to sell $1.50 million in this financing offer. The total financing amount was $1.50 million. This form was filed on 2016-09-30. The reason for the financing was: Amount is approximate. Consideration for the securities will be paid in New Zealand dollars in some cases and Australian dollars in others, and will fluctuate with changes in currency exchange rates.. The fundraising still has about $1.50 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Volpara Health Technologies is based in United Kingdom. The filler’s business is Biotechnology. The form D was submitted by Brian Leighs Chief Financial Officer. The company was incorporated more than five years ago. The filler’s address is: Level 12, 86 Victoria St., Wellington, Q2, New Zealand, 6011. Roger Allen is the related person in the form and it has address: 72 Bower St., Manly, C3, Australia, Nsw 2095. Link to Volpara Health Technologies Filing: 000168529416000003.
Analysis of Volpara Health Technologies Offering
On average, companies in the Biotechnology sector, sell 73.77% of the total offering amount. Volpara Health Technologies sold 0.00% of the offering. The fundraising is still open. The average fundraising amount for companies in the Biotechnology industry is $3.08 million. The offering was 100.00% smaller than the average of $3.08 million. Of course this should not be seen as negative. Businesses raise funds for a variety of needs and reasons. The minimum investment for this financing was set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Volpara Health Technologies Also
The Form D signed by Brian Leighs might help Volpara Health Technologies Ltd’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.